Anteris Technologies Global Corp.

AVR ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $1.0M $494.0K $310.0K $429.0K $618.0K $556.0K $536.0K $769.0K
Cost of Revenue $233.0K $114.0K $91.0K $123.0K $148.0K $207.0K $209.0K $443.0K
Gross Profit $776.0K $380.0K $219.0K $306.0K $470.0K $349.0K $327.0K $326.0K
Gross Margin 76.9% 76.9% 70.6% 71.3% 76.1% 62.8% 61.0% 42.4%
Operating Expenses
Research & Development $23.4M $17.5M $19.5M $16.8M $16.3M $16.5M $13.3M $13.9M
SG&A Expense $8.4M $6.9M $9.7M $5.8M $5.0M $5.7M $8.5M $7.0M
Operating Income $-31.0M $-24.0M $-29.0M $-22.3M $-20.9M $-21.8M $-21.5M $-20.6M
Operating Margin -3,072.1% -4,859.7% -9,343.5% -5,190.0% -3,379.3% -3,917.3% -4,014.7% -2,678.4%
Interest Expense $131.0K $27.0K $10.0K $15.0K $22.0K $26.0K $8.0K $11.0K
Pretax Income $-28.8M $-22.4M $-29.0M $-22.2M $-21.1M $-21.9M $-19.2M $-21.8M
Income Tax Expense $0 $492.0K $0 $0 $0 $0 $0 $0
Net Income $-29.1M $-23.0M $-29.2M $-22.2M $-20.8M $-21.9M $-19.4M $-21.9M
Net Margin -2,883.4% -4,660.7% -9,420.0% -5,185.1% -3,371.2% -3,932.4% -3,614.9% -2,842.4%
EPS (Basic) $-0.30 $-0.28 $-0.74 $-0.62 $-0.58 $-0.61 $-0.72 $-1.07
EPS (Diluted) $-0.30 $-0.28 $-0.74 $-0.62 $-0.58 $-0.61 $-0.72 $-1.07
Shares Outstanding (Basic) 97.3M 83.0M 36.9M 36.1M 36.1M 36.0M 20.3M 20.5M
Shares Outstanding (Diluted) 97.3M 83.0M 36.9M 36.1M 36.1M 36.0M 20.3M 20.5M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →